We have found that the ovarian cancer risk modifier SNP rs34259 may have a positive impact on UNG enzyme performance and is associated with lower oxidative levels in BRCA2 carriers, which may explain the cancer‐protective effect attributed to this SNP in this group. The gene discussed is BRCA2; the disease is ovarian carcinoma.